Theophylline suppresses IL-5 and IL-13 production, and lymphocyte proliferation upon stimulation with house dust mite in asthmatic children

International Archives of Allergy and Immunology

Volumn 131, Issue 3, 2003, Pages 189-194

  Kimura, Mitsuaki ^a   Okafuji, Ikuo ^a   Yoshida, Takami ^a  

^a SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Bronchial asthma; House dust mite; IL 13; IL 5; Lymphocyte proliferation; Theophylline

Indexed keywords

HOUSE DUST ALLERGEN; INTERLEUKIN 13; INTERLEUKIN 5; THEOPHYLLINE;

ADOLESCENT; ARTICLE; ASTHMA; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; TH2 CELL;

ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERLEUKIN-13; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; PYROGLYPHIDAE; THEOPHYLLINE;

EID: 0042665754     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071485     Document Type: Article

References (48)

1. Weinberger M: The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 1984;73:525-541.
2. Sly RM: Allergic disorders; in Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics, ed 16. Philadelphia, Saunders, 2000, pp 645-697.
3. Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadeen ER Jr: Emergency therapy of asthma: Comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980;122:365-371.
4. Punwels R, Van Renterghem D, Van Der Straeten M, Johannesson N, Persson GGA: The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985;76:583-590.
5. Crescioli S, Spinazzi A, Plebani M, Pozzani M, Mapp CE, Boschetto P, Fabbri LM: Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy 1991;66:245-251.
6. Persson CGD: Overview of effects of theophylline. J Allergy Clin Immunol 1989;78:780-787.
7. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ: Immunomodulation by theophylline in asthma: Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-1914.
8. Evans DJ, Taylor DA, Zetterstrom O, Chung KF O'Connor BJ, Barnes PJ: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-1418.
9. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J: Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-1008.
10. Mosmann TR, Cherwinski H, Bond MW, Giedlin MH, Coffman R: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secretory proteins. J Immunol 1986;136:2348-2357.
11. Parronchi P, Macchia D, Poccinni M-P, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S: Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538-4542.
12. Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
13. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin (IL-5) supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
14. Clutterbuck EJ, Hirst EMA, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, and GM-CSF. Blood 1989;73:1504-1512.
15. Martin LB, Kita H, Leiferman KM, Gleich GJ: Eosinophils in allergy: Role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996;109:207-215.
16. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR: Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-324.
17. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-1546.
18. Willis-Karp M: IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 2001;107:9-18.
19. Punnonen J, Aversa G, Cocks BG, Mckenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-3735.
20. Huang S-K, Xiao H-Q, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC: IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-2694.
21. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ: Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665.
22. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261.
23. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
24. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-2487.
25. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME: IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001;108:594-601.
26. Platts-Mills TAE, Vervloet D, Thomas WR, Aalberse RC, Chapman MD: Indoor allergens and asthma: Report of the third international workshop. J Allergy Clin Immunol 1997;100:S1-24.
27. Till S, Dickason R, Huston D, Humbert M, Robinson D, Larche M, Durham S, Kay AB, Corrigan C: IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease. J Allergy Clin Immunol 1997;99:563-569.
28. Kimura M, Tsuruta S, Yoshida T: Differences in cytokine production by peripheral blood mononuclear cells (PBMC) between patients with atopic dermatitis and bronchial asthma. Clin Exp Immunol 1999;118:192-196.
29. Kimura M, Tsuruta S, Yoshida T: IL-4 production by PBMCs on stimulation with mite allergen is correlated with the level of serum IgE antibody against mite in children with bronchial asthma. J Allergy Clin Immunol 2000;105:327-332.
30. Hiratani M, Muto K, Oshida Y, Ito S, Kasei M: Lymphocyte responsiveness to Dermatophagoides farinae extract in mite sensitive patients: Effect of immunotherapy on cellular proliferative response and specific immunoglobulin E antibody (RAST score). J Allergy Clin Immunol 1981;68:205-211.
31. Rawle FC, Mitchell EB, Platts-Mills TAE: T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, Antigen P1: Comparison of patients with asthma, atopic dermatitis, and perennial rhinitis. J Immunol 1984;133:195-201.
32. Linden J, Auchampach JA, Jin X, Figler RA: The structure and function of A1 and A2B adenosine receptors. Life Sci 1998;62:1519-1524.
33. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT: Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 1991;146:2712-2718.
34. Louis R, Bettiol J, Cataldo D, Radermecker M: Theophylline decreases sputum eosinophils of asthmatics. Int Arch Allergy Immunol 1999;118:343-344.
35. Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M, Miyazaki J, Sasaki Y, Hirose M, Imazu M: Suppression of airway inflammation by theophylline in adult bronchial asthma. Respiration 1999;66:124-127.
36. Aizawa H, Iwanaga T, Inoue H, Takata S, Matsumoto K, Takahashi N, Yoshida M, Hara N: Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics. Int Arch Allergy Immunol 2000;121:123-128.
37. Lim S, Tomita K, Carramori G, Jatakanon A, Oliver B, Keller A, Adcock I, Chung KF, Barnes PJ: Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med 2001;164:273-276.
38. Ohta K, Sawamoto S, Nakajima M, Kubota S, Tanaka Y, Miyasaka T, Nagai A, Hirai K, Mano K, Miyashita H: The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996;26(suppl 2):10-15.
39. Chung IY, Nam-Kung EK, Lee NM, Chang HS, Kim DJ, Kim YH, Park CS: The downregulation of Bcl-2 expression is necessary for theophylline-induced apoptosis of eosinophils. Cell Immunol 2000;203:95-102.
40. Kraft M, Pak J, Borish L, Martin RJ: Theophylline's effect on neutrophil function and the late asthmatic response. J Allergy Clin Immunol 1996;98:251-257.
41. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A: Theophylline accelerates human granulocyte apotosis not via phosphodiesterase inhibition. J Clin Invest 1997;100:1677-1684.
42. Kosmas EN, Michaelides SA, Polychronaki A, Roussou T, Toukmatzi S, Polychronopoulos V, Baxevanis CN: Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics. Eur Respir J 1999;13:53-58.
43. Bruserud Ø: The effect of theophyllamine on T-lymphocyte activation in vitro. Clin Immunol Immunopathol 1984;32:111-118.
44. Crocker IC, Townley RG, Khan MM: Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology 1996;31:223-235.
45. Yoshimura T, Nagao T, Nakao T, Watanabe S, Usami E, Kabayashi J, Yamazaki F, Tanaka H, Inagaki N, Nagai H: Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclar cells by phosphodiesterase inhibitors. Gen Pharmacol 1998;30:175-180.
46. Choy DKL, Ko F, Li ST, Ip LS, Leung R, Hui D, Lai KN, Lai CKW: Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells. Eur Respir J 1999;14:1106-1112.
47. Yoshida N, Shimizu Y, Kitaguchi K, Hiramatsu K, Takeuchi M, Ito Y, Kume H, Yamaki K, Suzuki R, Shibata E, Hasegawa T, Takagi K: Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells. Clin Exp Immunol 2001;126:384-389.
48. Kimura M, Tsuruta S, Yoshida T: Correlation of house dust mite-specific lymphocyte proliferation with interleukin 5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998;101:84-89.